Singapore markets closed

Bionano Genomics, Inc. (BNGO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
9.91-0.11 (-1.05%)
As of 11:22AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close10.02
Open10.09
Bid9.97 x 800
Ask9.97 x 2200
Day's range9.38 - 10.71
52-week range0.25 - 15.69
Volume14,418,204
Avg. volume87,600,381
Market cap2.695B
Beta (5Y monthly)2.37
PE ratio (TTM)N/A
EPS (TTM)-0.52
Earnings date12 Nov 2020
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est10.94
  • Is It Too Late to Buy Bionano Genomics Stock?
    Motley Fool

    Is It Too Late to Buy Bionano Genomics Stock?

    Bionano Genomics (NASDAQ: BNGO) has certainly created a buzz in 2021. It's one of the top 100 most-popular stocks on Robinhood. Bionano's shares have skyrocketed more than 340% so far this year.

  • Is BioNano Genomics Stock a Buy?
    Motley Fool

    Is BioNano Genomics Stock a Buy?

    If you don't have an answer to this (large, open-ended, highly technical) question, don't worry: BioNano Genomics (NASDAQ: BNGO) might. As its name implies, the company makes laboratory equipment that helps researchers and clinicians answer a narrow subset of those thorny genomics questions. BioNano's Saphyr genome mapping device detects large structural variations and aberrations in chromosomes, which is something that standard gene sequencers can't do.

  • Why Bionano Genomics Stock Surged Today
    Motley Fool

    Why Bionano Genomics Stock Surged Today

    What happened  Shares of Bionano Genomics (NASDAQ: BNGO) hit a record high on Friday. By the close of trading, the genome analysis company's stock price was up 17%. So what On Thursday, Bionano Genomics released a study showing that its Saphyr optical genome mapping (OGM) system could be used to analyze a wide variety of solid tumors in cancer research.